TRIP6 and neoplasm: While our in vitro experiments focused on tumor-cell-intrinsic functions, our computational analysis of patient data revealed a strong correlation between high TRIP6 expression and an immunosuppressive phenotype, including the downregulation of immune-activating signaling pathways.